In its boldest, most high-profile maneuver, Hims capitalized on a temporary regulatory loophole: an FDA-designated shortage of semaglutide, the active ingredient in blockbuster weight loss drugs like Ozempic and Wegovy
2025 comprehensive formulary, Kaiser Permanente 2025 Medicare Part D comprehensive formulary, Kaiser Permanente Criteria-based consultation prescribing program (injectable semaglutide), Kaiser Permanente Northwest Region Novo Nordisk receives FDA approval of Ozempic (semaglutide) injection for the treatment of adults with Type 2 diabetes, PR Newswire (2017) Understanding drug tiers, Patient Advocate Foundation Drug formulary (covered drugs), Kaiser Permanente Find out if your insurance covers Ozempic, NovoCare Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Retatrutide is a newer injectable that targets three hormonesGLP-1, GIP, and glucagonto help regulate appetite, metabolism, and blood sugar
Carnitine is often classified as an amino acid because of its chemical makeup
Neither peptide has received approval from Health Canada or the FDA for human therapeutic use
